Oxford Asset Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-41,723
| Closed | -$63.8K | – | 491 |
|
|
2025
Q1 | $63.8K | Buy |
+41,723
| New | +$63.8K | 0.03% | 434 |
|
|
2020
Q1 | – | Sell |
-27,599
| Closed | -$52K | – | 222 |
|
|
2019
Q4 | $52K | Buy |
+27,599
| New | +$52K | ﹤0.01% | 1664 |
|
|
2019
Q2 | – | Sell |
-35,230
| Closed | -$211K | – | 1667 |
|
|
2019
Q1 | $211K | Buy |
35,230
+12,072
| +52% | +$72.3K | ﹤0.01% | 1492 |
|
|
2018
Q4 | $171K | Buy |
+23,158
| New | +$171K | ﹤0.01% | 1571 |
|
|
2017
Q1 | – | Sell |
-38,781
| Closed | -$1.05M | – | 1384 |
|
|
2016
Q4 | $1.05M | Buy |
+38,781
| New | +$1.05M | 0.04% | 463 |
|